title: Inherent properties of adenylosuccinate lyase could explain S-Ado/SAICAr ratio due to homozygous R426H and R303C mutations.
abstract: Adenylosuccinate lyase (ADSL) is a homotetrameric enzyme involved in the de novo purine biosynthesis pathway and purine nucleotide cycle. Missense mutations in the protein lead to ADSL deficiency, an inborn error of purine metabolism characterized by neurological and physiological symptoms. ADSL deficiency is biochemically diagnosed by elevated levels of succinylaminoimidazolecarboxamide riboside (SAICAr) and succinyladenosine (S-Ado), the dephosphorylated derivatives of the substrates. S-Ado/SAICAr ratios have been associated with three phenotypic groups. Different hypotheses to explain these ratios have been proposed. Recent studies have focused on measuring activity on the substrates independently. However, it is important to examine mixtures of the substrates to determine if mutations affect enzyme activity on both substrates similarly in these conditions. The two substrates may experience an indirect communication due to being acted upon by the same enzyme, altering their activities from the non-competitive case. In this study, we investigate this hidden coupling between the two substrates. We chose two mutations that represent extremes of the phenotype, R426H and R303C. We describe a novel electrochemical-detection method of measuring the kinetic activity of ADSL in solution with its two substrates at varying concentration ratios. Furthermore, we develop an enzyme kinetic model to predict substrate activity from a given ratio of substrate concentrations. Our findings indicate a non-linear dependence of the activities on the substrate ratios due to competitive binding, distinct differences in the behaviors of the different mutations, and S-Ado/SAICAr ratios in patients could be explained by inherent properties of the mutant enzyme.
authors.affiliation: Department of Physics and Astronomy, University of Denver, Denver, CO, USA. Stephen.Ray@du.edu
authors.forename: Stephen P
authors.initials: SP
authors.lastname: Ray
authors.forename: Nathan
authors.initials: N
authors.lastname: Duval
authors.forename: Terry G
authors.initials: TG
authors.lastname: Wilkinson
authors.forename: Sean E
authors.initials: SE
authors.lastname: Shaheen
authors.forename: Kingshuk
authors.initials: K
authors.lastname: Ghosh
authors.forename: David
authors.initials: D
authors.lastname: Patterson
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives* / Q000378:metabolism; D000264:Adenylosuccinate Lyase / Q000172:deficiency / Q000235:genetics* / Q000378:metabolism; D000620:Aminoimidazole Carboxamide / Q000031:analogs & derivatives* / Q000378:metabolism; D001321:Autistic Disorder; D002851:Chromatography, High Pressure Liquid; D004563:Electrochemistry; D006720:Homozygote; D006801:Humans; D007700:Kinetics; D016297:Mutagenesis, Site-Directed; D020125:Mutation, Missense / Q000235:genetics*; D011686:Purine-Pyrimidine Metabolism, Inborn Errors / Q000175:diagnosis / Q000235:genetics*; D012265:Ribonucleotides / Q000378:metabolism*; D013379:Substrate Specificity
chemical_list: D012265:Ribonucleotides; D000620:Aminoimidazole Carboxamide; C043565:succinyladenosine; D000264:Adenylosuccinate Lyase; C020635:SAICAR; D000241:Adenosine